Scienture Holdings, Inc. — Director's Dealing 2021

Apr 15, 2021

SEC Form 4/A — Form 4/A

Issuer: TRXADE GROUP, INC. (MEDS)
CIK: 0001382574
Period of Report: 2020-12-14

Reporting Person: Fell Donald G. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-14	Common stock	S	500	$5.3	Disposed	9468	Direct

Footnotes

F1: The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person, to satisfy the Reporting Person's tax liability in connection with the December 2020 vesting of certain restricted stock shares which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3.

F2: This Amended Form 4 is being filed to update the Reporting Person's beneficial ownership to include 981 shares of common stock which were inadvertently
left out of the original filing.